CAS: 1194-21-4; 2-Amino-6-Chloropyrimidin-4(3H)-One

该化合物是一种环环流化合物,其特点是在氯化的湿米地主干柱上有氨基和羟基功能组群,这种结构有助于在制药和农用化学合成中应用多种用途,特别是作为生产活性成分的关键中间体.反应场所的存在可以进行选择性的修改,有利于目标分子的开发.在标准条件下,它的稳定可以确保合成工艺的一贯性.该化合物的纯度和定义明确的化学特性使它适合于研究和工业规模的应用,对再活性进行精确的控制是必不可少的.建议适当的处理和储存来保持其完整性.

结构式图片

相似化合物

55740-64-2 4765-77-9 108-53-2

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号56-05-3 2-氨基-4,6-二氯嘧啶 | CAS号1193-21-1 4,6-二氯嘧啶 | CAS号56-09-7 2-氨基-4,6-二羟基嘧啶 | CAS号5734-64-5 2-氨基-4-氯-6-甲氧基嘧啶 | CAS号1007-99-4 2-氨基-4-氯-5-硝基-6-羟基嘧啶 | CAS号164525-11-5 4(1H)-Pyrimidin... | CAS号56-05-3 2-氨基-4,6-二氯嘧啶 | CAS号5457-91-0 2,4-Pyrimidined...

合成工艺路线路线简述

    4,6-二氯嘧啶置于溶剂黄146体系中,用 Sodium Hydroxide 用作溶剂,以99%的收率获得2-氨基-6-氯-4-羟基嘧啶
    参考文献:Novel Intermediates For The Preparation Of Carbovir
    标题:Novel Intermediates For The Preparation Of Carbovir
    摘要:该发明提供了一种新型的环戊烯基醇化合物,可用作制备抗艾滋病药物卡波韦的中间体.还提供了制备这种新型化合物以及利用这些化合物制备卡波韦的方法.

    专利信息


    专利号:US-6818633-B2
    优先权日:2001-06-29
    标题:Antiviral compounds and methods for synthesis and therapy
    发明人:BALZARINI JAN M R; DE CLERCQ ERIK D A; HOLY ANTONIN
    权利人:ACAD OF SCIENCE CZECH REPUBLIC; REGA STICHTING
    摘要:Novel compounds are provided having formula (I)whereR1, R2, R3, R4, Z, X and * are defined herein. Also provided are antiviral methods for use and processes for synthesis of the compounds of formula (I).

    专利号:WO-2012127472-A1
    优先权日:2011-03-22
    标题:Process and intermediates for the preparation of preladenant and related compounds
    发明人:MAROM EHUD; MIZHIRITSKII MICHAEL; RUBNOV SHAI
    权利人:MAPI PHARMA LTD; MAROM EHUD; MIZHIRITSKII MICHAEL; RUBNOV SHAI
    摘要:The present invention describes processes for the synthesis of 2-(furan-2-yl)-7-[2-[4-[4-(2-methoxyethoxy)phenyl]piperazin-l-yl] ethyl]-7H-pyrazolo[ 4,3-e ][1,2,4]- triazolo[1,5c] pyrimidin-5-amine (Preladenant) represented by the structure of formula (1 ), and solvates and salts thereof, especially salts with pharmaceutically acceptable acids. The process of the present invention is useful not only for Preladenant production, but also for the preparation of other biologically active compounds of general formula (17), such as A2a receptor antagonists used for the treatment of central nervous system diseases, among others. The present invention further relates to certain intermediates formed in such processes.

    专利号:US-2005085492-A1
    优先权日:2003-10-20
    标 题:Stereoselective process for the synthesis of chiral garft compounds and intermediates
    发明人:RAHMAN LEERA
    权利人:AGOURON PHARMACEUTICALS MINC
    摘要:The present invention describes a stereoselective preparation of derivatives and precursors of molecules having formula 1: n nMethod of preparing the compounds, intermediates and derivatives are described. The methods described herein allow the preparation of diastereomeric forms of compound having formula 1. The compounds of the invention are GARFT inhibitors.

    专利号:US-3959278-A
    优先权日:1970-07-27
    标 题 :Method of synthesis of pteridines
    发明人:WOOD HAMISH CHRISTOPHER SWAN; STUART ALEXANDER; CURRAN ADRIAN CHARLES WARD; AL-HASSAN SAIEBA
    权利人:BURROUGHS WELLCOME CO
    摘要:A pharmaceutical formulation of a compound of formula (II') ##SPC1## n wherein Y is a lower alkyl group, in association with a pharmaceutically acceptable carrier, as an antibacterial product, and methods involving the preparation and reductive cyclization of a compound of formula (IV) ##SPC2## n wherein X is a lower alkyl group or a hydroxymethyl group.

    专利号:US-5401844-A
    优先权日:1983-04-11
    标 题 :Regulation of enzymes which utilize tetrahydrobiopterin or tetrahydrofolate cofactors with 6,6-disubstituted-tetrahydropteridines
    发明人:AYLING JUNE E; BAILEY STEVEN W
    权利人:UNIV SOUTH ALABAMA
    摘要:6-[2'-Amino-2',2'-disubstituted-ethylamino]-pyrimidines of the structure: ##STR1## in which X=H, NH 2 or NO 2 , which are novel intermediates in the synthesis of quinoid 6,6-disubstituted-dihydro- and 6,6-disubstituted-tetrahydro-pteridines, are claimed.

    专利号:US-11912734-B2
    优先权日:2020-01-28
    标题:Solid-phase synthesis of oligonucleotides containing N6-(2-deoxy-alpha,beta-derythropentofuranosyl)-2,6-diamino-4-hydroxy-5-formamidopyrimidine (Fapyâ‹…dG)
    发明人:GREENBERG MARC M; YANG HAOZHE
    权利人:UNIV JOHNS HOPKINS
    摘要:A strategy using reverse phosphoramidites for synthesizing oligonucleotides containing Fapy·dG is disclosed.
    南京哈柏医药科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.habotech.com
    电话: 025-85760892 13376090521👤
    📞南京哈柏医药科技有限公司 ⚠️参考联系方式

    销售电话:025-85760892 13376090521
    邮箱:sales@habotech.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    参考标题:The Synthesis Of 7-Deazaguanines As Potential Inhibitors Of Guanosine Triphosphate Cyclohydrolase I
    作者:Colin L Gibson,Salvatore La Rosa,Kyuji Ohta,Peter H Boyle,Fabien Leurquin,Alexandra Lemaçon,Colin J Suckling |发布日期:2004.1
    摘要:Compounds Can Be Prepared. These Methods Supplement Our Previous Work That Established Routes For The Synthesis Of 7- And 8-Substituted 7-Deazaguanines. Emphasis Is Placed On The Properties Of 2-Thioalkyl Pyrimidines As Intermediates Because They Provide The Basis For A Traceless Solid-State Synthesis Of Purines, Pteridines, And Their Analogues. Compounds Prepared Have Been Assessed In A Primary Screen For

    合成参考文献


    摘要:von Angerer, S., Science of Synthesis Knowledge Updates, (2011) 1, 335.
    摘要:von Angerer, S., Science of Synthesis Knowledge Updates, (2011) 1, 459.
    摘要:U.S. Army Armament Research & Development Command, Chemical Systems Laboratory, NIOSH Exchange Chemicals., NX#02771
    摘要:I. Wempen and J.J. Fox. J. Med. Chem. 6, 688 (1963).
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知